Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 118
Infectious Diseases Drugs 93
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 65
Genomics 59
Immune Disorders Drugs 57
Drug Discovery 47
Pharmaceuticals 44
Diabetes Drugs 42
Prostate Cancer Drugs 42
Vaccines 40
Biopharmaceuticals 39
Clinical Trials 37
Urological Disorders Drugs 35
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 29
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 26
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 25
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Surgical Procedures 20
Stem Cells 19
Analgesics 17
Oncology 17
Optical 14
Urology and Nephrology 13
Bladder Cancer Drugs 13
Infusions and Injectables 13
Diagnostics 13
Lung Cancer Drugs 12
Medical Devices 12
Drug Delivery 12
Dermatology 11
Pharmaceutical Manufacturing 10
Healthcare Services 9
Respiratory Drugs 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Needles and Syringes 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Pediatrics 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Skin Cancer Drugs 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anti-Obesity Drugs 1
Palliative Care 1
Anatomy 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,144 Results (Page 46 of 58)
- Relevance
  Sort by

Cancer Drugs Market - Global Forecast 2025-2032

 Report
November 2025
183 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Urothelial Cancer Drugs Market - Global Forecast 2025-2032

 Report
October 2025
195 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Persistent Facial Erythema Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
September 2024
89 Pages
Global

From

€3500EUR$4,257USD£3,184GBP

Antitumor ADC Drugs Market - Global Forecast 2025-2030

 Report
August 2025
196 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Alfuzosin Hydrochloride Tablets Market - Global Forecast 2025-2030

 Report
August 2025
184 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cerebral Palsy Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Neuralgia Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Global Regenerative Medicine Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type, Material, Application, and Region

 Report
November 2022
150 Pages
Global

From

€4272EUR$4,850USD£3,755GBP

Alpha Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1409EUR$1,600USD£1,239GBP

€1762EUR$2,000USD£1,548GBP

Pruritus Therapeutics Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4184EUR$4,750USD£3,677GBP

Muscarinic Acetylcholine Receptor Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Blastic Plasmacytoid Dendritic Cell Neoplasm Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Insomnia Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Chronic Obstructive Pulmonary Disorder Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,257USD£3,184GBP

Beta Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1057EUR$1,200USD£929GBP

€1321EUR$1,500USD£1,161GBP

Telmisartan Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2025-2034)

 Report
June 2025
400 Pages
Global

From

€4359EUR$4,949USD£3,831GBP

Spinal Muscular Atrophy - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1409EUR$1,600USD£1,239GBP

€1762EUR$2,000USD£1,548GBP

Reversible Anticholinesterases - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1057EUR$1,200USD£929GBP

€1321EUR$1,500USD£1,161GBP

Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
102 Pages
Global

From

€3963EUR$4,500USD£3,484GBP

Chronic Kidney Disease: Global Markets and Technologies Through 2023

 Report
April 2019
153 Pages
Global

From

€2422EUR$2,750USD£2,129GBP

1,144 Results (Page 46 of 58)
- 1
- 44
- 45
- 46
- 47
- 48

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.